The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
GSK-3 as potential target for therapeutic intervention in cancer
Open accessAbstract
// James A. McCubrey 1 , Linda S. Steelman 1 , Fred E. Bertrand 2 , Nicole M. Davis 1 , Melissa Sokolosky 1 , Steve L. Abrams 1 , Giuseppe Montalto 3 , Antonino B. D’Assoro 4 , Massimo Libra 5 , Ferdinando Nicoletti 5 , Roberta Maestro 6 , Jorg Basecke 7,8 , Dariusz Rakus 9 , Agnieszka Gizak 9 Zoya Demidenko 10 , Lucio Cocco 11 , Alberto M. Martelli 11 and Melchiorre Cervello 12 1 Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University Greenville, NC, USA 2 Department of Oncology, Brody School of Medicine at East Carolina University Greenville, NC, USA 3 Biomedical Department of Internal Medicine and Specialties, University of Palermo, Palermo, Italy 4 Department of Medical Oncology, Mayo Clinic Cancer Center, Rochester, MN, USA 5 Department of Bio-Medical Sciences, University of Catania, Catania, Italy 6 Experimental Oncology 1, CRO IRCCS, National Cancer Institute, Aviano, Pordenone, Italy. 7 Department of Medicine, University of Göttingen, Göttingen, Germany 8 Sanct-Josef-Hospital Cloppenburg, Department of Hematology and Oncology, Cloppenburg, Germany 9 Department of Animal Molecular Physiology, Institute of Experimental Biology, Wroclaw University, Wroclaw, Poland 10 Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA 11 Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy 12 Consiglio Nazionale delle Ricerche, Istituto di Biomedicina e Immunologia Molecolare “Alberto Monroy”, Palermo, Italy Correspondence: James A. McCubrey, email: // Keywords : GSK-3, cancer stem cells, Wnt/beta-catenin, PI3K, Akt, mTOR, Hedgehog, Notch, Targeted Therapy, Therapy Resistance, Mutations, Rapamycin Received : April 24, 2014 Accepted : May 28, 2014 Published : May 28, 2014 Abstract The serine/threonine kinase glycogen synthase kinase-3 (GSK-3) was initially identified and studied in the regulation of glycogen synthesis. GSK-3 functions in a wide range of cellular processes. Aberrant activity of GSK-3 has been implicated in many human pathologies including: bipolar depression, Alzheimer’s disease, Parkinson’s disease, cancer, non-insulin-dependent diabetes mellitus (NIDDM) and others. In some cases, suppression of GSK-3 activity by phosphorylation by Akt and other kinases has been associated with cancer progression. In these cases, GSK-3 has tumor suppressor functions. In other cases, GSK-3 has been associated with tumor progression by stabilizing components of the beta-catenin complex. In these situations, GSK-3 has oncogenic properties. While many inhibitors to GSK-3 have been developed, their use remains controversial because of the ambiguous role of GSK-3 in cancer development. In this review, we will focus on the diverse roles that GSK-3 plays in various human cancers, in particular in solid tumors. Recently, GSK-3 has also been implicated in the generation of cancer stem cells in various cell types. We will also discuss how this pivotal kinase interacts with multiple signaling pathways such as: PI3K/PTEN/Akt/mTORC1, Ras/Raf/MEK/ERK, Wnt/beta-catenin, Hedgehog, Notch and others.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Notch signalling: a simple pathway becomes complex
Bray, S. J. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2009 · Cited by 2,620
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130
Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., & Brivanlou, A. H. (2004) · Nature Medicine · doi:10.1038/nm979 · Cited by 2,109
A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain
De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J. S., Schroeter, E. H., Schrijvers, V., Wolfe, M. S., Ray, W. J., et al. (1999) · Nature · doi:10.1038/19083 · Cited by 2,100
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism
Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G.-H., Tan, Y., Zhang, Z., Lin, X., & He, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00685-2 · Cited by 2,069
A human memory T cell subset with stem cell–like properties
Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C. M., Quigley, M. F., Almeida, J. R., Gostick, E., Yu, Z., Carpenito, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2446 · Cited by 1,974 · cited 1×
“Importantly inhibition of GSK-3, mTORC1 or both may augment the number and competence of CD8+ memory T cells [210-212].”
WNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3419 · Cited by 1,911
Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain
Schroeter, E. H., Kisslinger, J. A., & Kopan, R. (1998) · Nature · doi:10.1038/30756 · Cited by 1,624
Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly
Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., & Polakis, P. (1996) · Science · doi:10.1126/science.272.5264.1023 · Cited by 1,422
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M.-S., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,393
Carracedo, A., Ma, L., Teruya-Feldstein, J., Rojo, F., Salmena, L., Alimonti, A., Egia, A., Sasaki, A. T., Thomas, G., Kozma, S. C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34739 · Cited by 1,381
Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.055 · Cited by 1,377
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321
Ikeda, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1371 · Cited by 1,246
AMPK and PPARδ Agonists Are Exercise Mimetics
Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y.-X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.051 · Cited by 1,222
Peterson, T. R., Laplante, M., Thoreen, C. C., Sancak, Y., Kang, S. A., Kuehl, W. M., Gray, N. S., & Sabatini, D. M. (2009) · Cell · doi:10.1016/j.cell.2009.03.046 · Cited by 1,202
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
Yilmaz, Ö. H., Valdez, R., Theisen, B. K., Guo, W., Ferguson, D. O., Wu, H., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature04703 · Cited by 1,113
Embi, N., Rylatt, D. B., & Cohen, P. (1980) · PubMed · Cited by 911
Sutherland, C., Leighton, I. A., & Cohen, P. (1993) · Biochemical Journal · doi:10.1042/bj2960015 · Cited by 903
Regulation of osteoblastogenesis and bone mass by Wnt10b
Bennett, C. N., Longo, K. A., Wright, W. S., Suva, L. J., Lane, T. F., Hankenson, K. D., & MacDougald, O. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408742102 · Cited by 881
GSK3: a multifaceted kinase in Wnt signaling
Wu, D., & Pan, W. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.10.002 · Cited by 857
Hes1 and Hes5 as Notch effectors in mammalian neuronal differentiation
Ohtsuka, T., Ishibashi, M., Gradwohl, G., Nakanishi, S., Guillemot, F., & Kageyama, R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2196 · Cited by 852
A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation
Zeng, X., Tamai, K., Doble, B., Li, S., Huang, H., Habas, R., Okamura, H., Woodgett, J., & He, X. (2005) · Nature · doi:10.1038/nature04185 · Cited by 849
GSK3 signalling in neural development
Hur, E.-M., & Zhou, F.-Q. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2870 · Cited by 838
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A
Fang, X., Yu, S. X., Lu, Y., Bast, R. C., Woodgett, J. R., & Mills, G. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220413597 · Cited by 830
GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins
Meijer, L., Skaltsounis, A.-L., Magiatis, P., Polychronopoulos, P., Knockaert, M., Leost, M., Ryan, X. P., Vonica, C. A., Brivanlou, A., Dajani, R., et al. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.11.010 · Cited by 808
Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7
Yada, M., Hatakeyama, S., Kamura, T., Nishiyama, M., Tsunematsu, R., Imaki, H., Ishida, N., Okumura, F., Nakayama, K., & Nakayama, K. I. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600217 · Cited by 808
Lin, S.-Y., Xia, W., Wang, J. C., Kwong, K. Y., Spohn, B., Wen, Y., Pestell, R. G., & Hung, M.-C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060025397 · Cited by 783
EMBI, N., RYLATT, D. B., & COHEN, P. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06059.x · Cited by 779
Axin-mediated CKI phosphorylation of β-catenin at Ser 45: a molecular switch for the Wnt pathway
Amit, S., Hatzubai, A., Birman, Y., Andersen, J. S., Ben-Shushan, E., Mann, M., Ben-Neriah, Y., & Alkalay, I. (2002) · Genes & Development · doi:10.1101/gad.230302 · Cited by 753
Nuclear Access and Action of Notch In Vivo
Struhl, G., & Adachi, A. (1998) · Cell · doi:10.1016/s0092-8674(00)81193-9 · Cited by 733
A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance
Ito, K., Carracedo, A., Weiss, D., Arai, F., Ala, U., Avigan, D. E., Schafer, Z. T., Evans, R. M., Suda, T., Lee, C.-H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2882 · Cited by 729
Frame, S., Cohen, P., & Biondi, R. M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00253-2 · Cited by 701
Chen, C., Liu, Y., Liu, R., Ikenoue, T., Guan, K.-L., Liu, Y., & Zheng, P. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081297 · Cited by 682
mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells
Chen, C., Liu, Y., Liu, Y., & Zheng, P. (2009) · Science Signaling · doi:10.1126/scisignal.2000559 · Cited by 680
Gillett, C., Fantl, V., Smith, D., Fisher, C., Bartek, J. J., Dickson, C., Barnes, D. M., & Peters, G. (1994) · PubMed · Cited by 661
Activation of the Wnt Signaling Pathway: A Molecular Mechanism for Lithium Action
Hedgepeth, C. M., Conrad, L. J., Zhang, J., Huang, H.-C., Lee, V. M. Y., & Klein, P. S. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8552 · Cited by 636
Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation.
Hughes, K., Nikolakaki, E., Plyte, S. E., Totty, N. F., & Woodgett, J. R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05715.x · Cited by 629
A Wnt–Axin2–GSK3β cascade regulates Snail1 activity in breast cancer cells
Yook, J. I., Li, X.-Y., Ota, I., Hu, C., Kim, H. S., Kim, N. H., Cha, S. Y., Ryu, J. K., Choi, Y. J., Kim, J., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1508 · Cited by 616
Paths to stemness: building the ultimate antitumour T cell
Gattinoni, L., Klebanoff, C. A., & Restifo, N. P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3322 · Cited by 599
Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin
Ding, Q., Xia, W., Liu, J.-C., Yang, J.-Y., Lee, D.-F., Xia, J., Bartholomeusz, G., Li, Y., Pan, Y., Li, Z., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.009 · Cited by 597
Mitogen inactivation of glycogen synthase kinase-3 β in intact cells via serine 9 phosphorylation
Stambolic, V, & Woodgett, J. R. (1994) · Biochemical Journal · doi:10.1042/bj3030701 · Cited by 581
Casein kinase 1 γ couples Wnt receptor activation to cytoplasmic signal transduction
Davidson, G., Wu, W., Shen, J., Bilic, J., Fenger, U., Stannek, P., Glinka, A., & Niehrs, C. (2005) · Nature · doi:10.1038/nature04170 · Cited by 581
Integrating Patterning Signals: Wnt/GSK3 Regulates the Duration of the BMP/Smad1 Signal
Fuentealba, L. C., Eivers, E., Ikeda, A., Hurtado, C., Kuroda, H., Pera, E. M., & De Robertis, E. M. (2007) · Cell · doi:10.1016/j.cell.2007.09.027 · Cited by 554
Steelman, L. S., Chappell, W. H., Abrams, S. L., Kempf, C. R., Long, J., Laidler, P., Mijatovic, S., Maksimovic-Ivanic, D., Stivala, F., Mazzarino, M. C., et al. (2011) · Aging · doi:10.18632/aging.100296 · Cited by 553
Self-citationPML targeting eradicates quiescent leukaemia-initiating cells
Ito, K., Bernardi, R., Morotti, A., Matsuoka, S., Saglio, G., Ikeda, Y., Rosenblatt, J., Avigan, D. E., Teruya-Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07016 · Cited by 538
Ring, D. B., Johnson, K. W., Henriksen, E. J., Nuss, J. M., Goff, D., Kinnick, T. R., Ma, S. T., Reeder, J. W., Samuels, I., Slabiak, T., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.3.588 · Cited by 532
Molecular Targets of Lithium Action
Phiel, C. J., & Klein, P. S. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.789 · Cited by 515
Cyclin D1 protein expression and function in human breast cancer
Bartkova, J., Lukas, J., Müller, H., Lützhøt, D., Strauss, M., & Bartek, J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570311 · Cited by 509
Zeng, X., Huang, H., Tamai, K., Zhang, X., Harada, Y., Yokota, C., Almeida, K., Wang, J., Doble, B., Woodgett, J., et al. (2008) · Development · doi:10.1242/dev.013540 · Cited by 492
Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3β Inactivation
Thornton, T. M., Pedraza-Alva, G., Deng, B., Wood, C. D., Aronshtam, A., Clements, J. L., Sabio, G., Davis, R. J., Matthews, D. E., Doble, B., et al. (2008) · Science · doi:10.1126/science.1156037 · Cited by 484
Mammalian Suppressor-of-Fused modulates nuclear–cytoplasmic shuttling of GLI-1
Kogerman, P., Grimm, T., Kogerman, L., Krause, D., Undén, A. B., Sandstedt, B., Toftgård, R., & Zaphiropoulos, P. G. (1999) · Nature Cell Biology · doi:10.1038/13031 · Cited by 476
Phosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear Localization
Gregory, M. A., Qi, Y., & Hann, S. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310722200 · Cited by 475
Wnt Signaling Controls the Phosphorylation Status of β-Catenin
van Noort, M., Meeldijk, J., van der Zee, R., Destree, O., & Clevers, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111635200 · Cited by 469
The myc Oncogene: arvelouslomplex
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)84004-0 · Cited by 463
The hematopoietic stem cell in its place
Adams, G. B., & Scadden, D. T. (2006) · Nature Immunology · doi:10.1038/ni1331 · Cited by 454
Doble, B. W., Patel, S., Wood, G. A., Kockeritz, L. K., & Woodgett, J. R. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.04.001 · Cited by 448
Modulation of PPAR activity via phosphorylation
BURNS, K., & VANDENHEUVEL, J. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.04.018 · Cited by 443
Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling
Riobó, N. A., Lu, K., Ai, X., Haines, G. M., & Emerson, C. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504337103 · Cited by 439
Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells
Gan, B., Hu, J., Jiang, S., Liu, Y., Sahin, E., Zhuang, L., Fletcher-Sananikone, E., Colla, S., Wang, Y. A., Chin, L., et al. (2010) · Nature · doi:10.1038/nature09595 · Cited by 435
A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial–mesenchymal transition
Kim, N. H., Kim, H. S., Li, X.-Y., Lee, I., Choi, H.-S., Kang, S. E., Cha, S. Y., Ryu, J. K., Yoon, D., Fearon, E. R., et al. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201103097 · Cited by 432
Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy
Luo, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.05.045 · Cited by 429
Differential Regulation of Glycogen Synthase Kinase 3β by Insulin and Wnt Signaling
Ding, V. W., Chen, R.-H., & McCormick, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005342200 · Cited by 427
Wilms Tumor Suppressor WTX Negatively Regulates WNT/ß-Catenin Signaling
Major, M. B., Camp, N. D., Berndt, J. D., Yi, X., Goldenberg, S. J., Hubbert, C., Biechele, T. L., Gingras, A.-C., Zheng, N., MacCoss, M. J., et al. (2007) · Science · doi:10.1126/science/1141515 · Cited by 405
The Hedgehog's tale: developing strategies for targeting cancer
Ng, J. M. Y., & Curran, T. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3079 · Cited by 398
Ding, Q., He, X., Hsu, J.-M., Xia, W., Chen, C.-T., Li, L.-Y., Lee, D.-F., Liu, J.-C., Zhong, Q., Wang, X., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00620-06 · Cited by 393
The Lkb1 metabolic sensor maintains haematopoietic stem cell survival
Gurumurthy, S., Xie, S. Z., Alagesan, B., Kim, J., Yusuf, R. Z., Saez, B., Tzatsos, A., Ozsolak, F., Milos, P., Ferrari, F., et al. (2010) · Nature · doi:10.1038/nature09572 · Cited by 391
Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription
Bachelder, R. E., Yoon, S.-O., Franci, C., de Herreros, A. G., & Mercurio, A. M. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200409067 · Cited by 390
PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR
Bernardi, R., Guernah, I., Jin, D., Grisendi, S., Alimonti, A., Teruya-Feldstein, J., Cordon-Cardo, C., Celeste Simon, M., Rafii, S., & Pandolfi, P. P. (2006) · Nature · doi:10.1038/nature05029 · Cited by 378
Linseman, D. A., Butts, B. D., Precht, T. A., Phelps, R. A., Le, S. S., Laessig, T. A., Bouchard, R. J., Florez-McClure, M. L., & Heidenreich, K. A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2057-04.2004 · Cited by 370
Bhat, R. V., Shanley, J., Correll, M. P., Fieles, W. E., Keith, R. A., Scott, C. W., & Lee, C.-M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190297597 · Cited by 366
Yamamoto, H., Kishida, S., Kishida, M., Ikeda, S., Takada, S., & Kikuchi, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10681 · Cited by 364
Multisite Phosphorylation by Cdk2 and GSK3 Controls Cyclin E Degradation
Welcker, M., Singer, J., Loeb, K. R., Grim, J., Bloecher, A., Gurien-West, M., Clurman, B. E., & Roberts, J. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00287-9 · Cited by 363
Role of Glycogen Synthase Kinase-3β in Cardioprotection
Juhaszova, M., Zorov, D. B., Yaniv, Y., Nuss, H. B., Wang, S., & Sollott, S. J. (2009) · Circulation Research · doi:10.1161/circresaha.109.197996 · Cited by 352
The ground state of pluripotency
Wray, J., Kalkan, T., & Smith, A. G. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381027 · Cited by 350
What Are the bona fide GSK3 Substrates?
Sutherland, C. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/505607 · Cited by 345
Dravid, G., Ye, Z., Hammond, H., Chen, G., Pyle, A., Donovan, P., Yu, X., & Cheng, L. (2005) · STEM CELLS · doi:10.1634/stemcells.2005-0034 · Cited by 342
Espinosa, L., Inglés-Esteve, J., Aguilera, C., & Bigas, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304001200 · Cited by 337
Jouve, C., Palmeirim, I., Henrique, D., Beckers, J., Gossler, A., Ish-Horowicz, D., & Pourquié, O. (2000) · Development · doi:10.1242/dev.127.7.1421 · Cited by 331
Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study
del Ser, T., Steinwachs, K. C., Gertz, H. J., Andrés, M. V., Gómez-Carrillo, B., Medina, M., Vericat, J. A., Redondo, P., Fleet, D., & León, T. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120805 · Cited by 329
Ougolkov, A. V., Fernandez-Zapico, M. E., Savoy, D. N., Urrutia, R. A., & Billadeau, D. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3642 · Cited by 327
COLE, A., FRAME, S., & COHEN, P. (2004) · Biochemical Journal · doi:10.1042/bj20031259 · Cited by 324
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Franklin, R. A., Montalto, G., Cervello, M., Libra, M., Candido, S., Malaponte, G., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.659 · Cited by 314
Self-citationp53 and MicroRNA-34 Are Suppressors of Canonical Wnt Signaling
Kim, N. H., Kim, H. S., Kim, N.-G., Lee, I., Choi, H.-S., Li, X.-Y., Kang, S. E., Cha, S. Y., Ryu, J. K., Na, J. M., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001744 · Cited by 308
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Montalto, G., Cervello, M., Nicoletti, F., Fagone, P., Malaponte, G., Mazzarino, M. C., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.652 · Cited by 306
Self-citationGlycogen Synthase Kinase 3α-Specific Regulation of Murine Hepatic Glycogen Metabolism
MacAulay, K., Doble, B. W., Patel, S., Hansotia, T., Sinclair, E. M., Drucker, D. J., Nagy, A., & Woodgett, J. R. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.013 · Cited by 299
Bahram, F., von der Lehr, N., Cetinkaya, C., & Larsson, L.-G. (2000) · Blood · doi:10.1182/blood.v95.6.2104 · Cited by 286
Glycogen Synthase Kinase-3 - An Overview of An Over-Achieving Protein Kinase
Kockeritz, L., Doble, B., Patel, S., & Woodgett, J. (2006) · Current Drug Targets · doi:10.2174/1389450110607011377 · Cited by 284
The sirtuins, oxidative stress and aging: an emerging link
Merksamer, P. I., Liu, Y., He, W., Hirschey, M. D., Chen, D., & Verdin, E. (2013) · Aging · doi:10.18632/aging.100544 · Cited by 275
Wang, H., Wang, H.-S., Zhou, B.-H., Li, C.-L., Zhang, F., Wang, X.-F., Zhang, G., Bu, X.-Z., Cai, S.-H., & Du, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056664 · Cited by 273
Shakoori, A., Ougolkov, A., Yu, Z. W., Zhang, B., Modarressi, M. H., Billadeau, D. D., Mai, M., Takahashi, Y., & Minamoto, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.041 · Cited by 272
Glycogen Synthase Kinase-3β Modulates Notch Signaling and Stability
Foltz, D. R., Santiago, M. C., Berechid, B. E., & Nye, J. S. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00888-6 · Cited by 271
Wang, Y., Lam, J. B., Lam, K. S. L., Liu, J., Lam, M. C., Hoo, R. L. C., Wu, D., Cooper, G. J. S., & Xu, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1969 · Cited by 270
Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy
Wang, Z., Smith, K. S., Murphy, M., Piloto, O., Somervaille, T. C. P., & Cleary, M. L. (2008) · Nature · doi:10.1038/nature07284 · Cited by 265
McCubrey, J. A., Steelman, L. S., Bertrand, F. E., Davis, N. M., Abrams, S. L., Montalto, G., D'Assoro, A. B., Libra, M., Nicoletti, F., Maestro, R., et al. (2014) · Leukemia · doi:10.1038/leu.2013.184 · Cited by 255
Self-citationPhosphorylation of Serine 468 by GSK-3β Negatively Regulates Basal p65 NF-κB Activity
Buss, H., Dörrie, A., Schmitz, M. L., Frank, R., Livingstone, M., Resch, K., & Kracht, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400442200 · Cited by 252
Qu, L., Huang, S., Baltzis, D., Rivas-Estilla, A.-M., Pluquet, O., Hatzoglou, M., Koumenis, C., Taya, Y., Yoshimura, A., & Koromilas, A. E. (2004) · Genes & Development · doi:10.1101/gad.1165804 · Cited by 245
Lesort, M., Jope, R. S., & Johnson, G. V. W. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720576.x · Cited by 240
Moore, G. J., Cortese, B. M., Glitz, D. A., Zajac-Benitez, C., Quiroz, J. A., Uhde, T. W., Drevets, W. C., & Manji, H. K. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.07m03745 · Cited by 234
Smalley, K. S. M., Contractor, R., Haass, N. K., Kulp, A. N., Atilla-Gokcumen, G. E., Williams, D. S., Bregman, H., Flaherty, K. T., Soengas, M. S., Meggers, E., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1538 · Cited by 230
LKB1 and AMPK Family Signaling: The Intimate Link Between Cell Polarity and Energy Metabolism
Jansen, M., ten Klooster, J. P., Offerhaus, G. J., & Clevers, H. (2009) · Physiological Reviews · doi:10.1152/physrev.00026.2008 · Cited by 221
Glycogen Synthase Kinase-3 Couples AKT-dependent Signaling to the Regulation of p21Cip1 Degradation
Rössig, L., Badorff, C., Holzmann, Y., Zeiher, A. M., & Dimmeler, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106157200 · Cited by 218
Glycogen synthase kinase 3: A point of convergence for the host inflammatory response
Wang, H., Brown, J., & Martin, M. (2011) · Cytokine · doi:10.1016/j.cyto.2010.10.009 · Cited by 216
Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways
Huang, J., Nguyen-McCarty, M., Hexner, E. O., Danet-Desnoyers, G., & Klein, P. S. (2012) · Nature Medicine · doi:10.1038/nm.2984 · Cited by 215
Chen, J., Chan, A. W. H., To, K.-F., Chen, W., Zhang, Z., Ren, J., Song, C., Cheung, Y.-S., Lai, P. B. S., Cheng, S.-H., et al. (2013) · Hepatology · doi:10.1002/hep.26278 · Cited by 214
Martelli, A. M., Evangelisti, C., Chappell, W., Abrams, S. L., Bäsecke, J., Stivala, F., Donia, M., Fagone, P., Nicoletti, F., Libra, M., et al. (2011) · Leukemia · doi:10.1038/leu.2011.46 · Cited by 204
Self-citationProapoptotic Stimuli Induce Nuclear Accumulation of Glycogen Synthase Kinase-3β
Bijur, G. N., & Jope, R. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105725200 · Cited by 204
microRNA-451: A conditional switch controlling glioma cell proliferation and migration
Godlewski, J., Bronisz, A., Nowicki, M. O., Chiocca, E. A., & Lawler, S. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12248 · Cited by 203
Casein kinase I phosphorylates the Armadillo protein and induces its degradation in Drosophila
Yanagawa, S.-I. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1733 · Cited by 201
Bax, B., Carter, P. S., Lewis, C., Guy, A. R., Bridges, A., Tanner, R., Pettman, G., Mannix, C., Culbert, A. A., Brown, M. J. B., et al. (2001) · Structure · doi:10.1016/s0969-2126(01)00679-7 · Cited by 200
Glycogen Synthase Kinase 3 Is an Insulin-Regulated C/EBPα Kinase
Ross, S. E., Erickson, R. L., Hemati, N., & MacDougald, O. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8433 · Cited by 197
Sato, T., Nakashima, A., Guo, L., & Tamanoi, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809207200 · Cited by 196
Zhao, Y., Altman, B. J., Coloff, J. L., Herman, C. E., Jacobs, S. R., Wieman, H. L., Wofford, J. A., Dimascio, L. N., Ilkayeva, O., Kelekar, A., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00153-07 · Cited by 193
Glycogen synthase kinase 3 beta: can it be a target for oral cancer
Mishra, R. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-144 · Cited by 190
Schwarz-Romond, T., Asbrand, C., Bakkers, J., Kühl, M., Schaeffer, H.-J., Huelsken, J., Behrens, J., Hammerschmidt, M., & Birchmeier, W. (2002) · Genes & Development · doi:10.1101/gad.230402 · Cited by 189
Ougolkov, A. V., Bone, N. D., Fernandez-Zapico, M. E., Kay, N. E., & Billadeau, D. D. (2007) · Blood · doi:10.1182/blood-2006-12-060947 · Cited by 187
Glycogen synthase kinase-3β positively regulates the proliferation of human ovarian cancer cells
Cao, Q., Lu, X., & Feng, Y.-J. (2006) · Cell Research · doi:10.1038/sj.cr.7310078 · Cited by 186
Lee, J. Y., Nakada, D., Yilmaz, O. H., Tothova, Z., Joseph, N. M., Lim, M. S., Gilliland, D. G., & Morrison, S. J. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.09.015 · Cited by 185
Bennecib, M., Gong, C.-X., Grundke-Iqbal, I., & Iqbal, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02203-1 · Cited by 184
Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells
Curtin, J. C., & Lorenzi, M. V. (2010) · Oncotarget · doi:10.18632/oncotarget.191 · Cited by 182
Signaling pathways in schizophrenia: emerging targets and therapeutic strategies
Karam, C. S., Ballon, J. S., Bivens, N. M., Freyberg, Z., Girgis, R. R., Lizardi-Ortiz, J. E., Markx, S., Lieberman, J. A., & Javitch, J. A. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.05.004 · Cited by 178
Abnormalities in brain structure and behavior in GSK-3alpha mutant mice
Kaidanovich-Beilin, O., Lipina, T. V., Takao, K., van Eede, M., Hattori, S., Laliberté, C., Khan, M., Okamoto, K., Chambers, J. W., Fletcher, P. J., et al. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-35 · Cited by 177
Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer
Dickson, C., Fantl, V., Gillett, C., Brookes, S., Bartek, J., Smith, R., Fisher, C., Barnes, D., & Peters, G. (1995) · Cancer Letters · doi:10.1016/0304-3835(94)03676-a · Cited by 176
Does Lithium Prevent Alzheimerʼs Disease?
Forlenza, O. V., de Paula, V. J., Machado-Vieira, R., Diniz, B. S., & Gattaz, W. F. (2012) · Drugs & Aging · doi:10.2165/11599180-000000000-00000 · Cited by 172
Targeted therapy for hepatocellular carcinoma: novel agents on the horizon
Cervello, M., McCubrey, J. A., Cusimano, A., Lampiasi, N., Azzolina, A., & Montalto, G. (2012) · Oncotarget · doi:10.18632/oncotarget.466 · Cited by 170
Self-citationHedgehog Fights Back: Mechanisms of Acquired Resistance against Smoothened Antagonists
Metcalfe, C., & de Sauvage, F. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0923 · Cited by 168
Shin, S., Wolgamott, L., Yu, Y., Blenis, J., & Yoon, S.-O. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110195108 · Cited by 165
Gao, C., Hölscher, C., Liu, Y., & Li, L. (2012) · revneuro · doi:10.1515/rns.2011.061 · Cited by 164
Deconstructing GSK‐3: The Fine Regulation of Its Activity
Medina, M., & Wandosell, F. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/479249 · Cited by 161
Kinase-Inactive Glycogen Synthase Kinase 3β Promotes Wnt Signaling and Mammary Tumorigenesis
Farago, M., Dominguez, I. M., Landesman‐Bollag, E., Xu, X., Rosner, A., Cardiff, R. D., & Seldin, D. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1021 · Cited by 152
Phosphorylation of AKT: a Mutational Analysis
Hart, J. R., & Vogt, P. K. (2011) · Oncotarget · doi:10.18632/oncotarget.293 · Cited by 145
Mcl-1 Integrates the Opposing Actions of Signaling Pathways That Mediate Survival and Apoptosis
Morel, C., Carlson, S. M., White, F. M., & Davis, R. J. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00279-09 · Cited by 143
The mechanism by which epidermal growth factor inhibits glycogen synthase kinase 3 in A431 cells
Saito, Y., Vandenheede, J. R., & Cohen, P. (1994) · Biochemical Journal · doi:10.1042/bj3030027 · Cited by 143
Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance (Review)
Libra, M. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1312 · Cited by 142
Self-citationInhibition of GSK‐3β activity attenuates proliferation of human colon cancer cells in rodents
Shakoori, A., Mai, W., Miyashita, K., Yasumoto, K., Takahashi, Y., Ooi, A., Kawakami, K., & Minamoto, T. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00545.x · Cited by 136
Sanchez, J. F., Sniderhan, L. F., Williamson, A. L., Fan, S., Chakraborty‐Sett, S., & Maggirwar, S. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.13.4649-4662.2003 · Cited by 134
Wnt/Β-Catenin and Sex Hormone Signaling In Endometrial Homeostasis and Cancer
Wang, Y., van der Zee, M., Fodde, R., & Blok, L. J. (2010) · Oncotarget · doi:10.18632/oncotarget.201 · Cited by 134
Evidence that glycogen synthase kinase‐3 isoforms have distinct substrate preference in the brain
Soutar, M. P. M., Kim, W.-Y., Williamson, R., Peggie, M. W., Hastie, C. J., McLauchlan, H., Snider, W. D., Gordon‐Weeks, P. R., & Sutherland, C. D. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06988.x · Cited by 133
Tan, J. Y., Zhuang, L., Leong, H. S., Iyer, N. G., Liu, E. T., & Yu, Q. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1226 · Cited by 132
Pivotal role for glycogen synthase kinase–3 in hematopoietic stem cell homeostasis in mice
Huang, J. Y., Zhang, Y., Bersenev, A., O’Brien, W. T., Tong, W., Emerson, S. G., & Klein, P. S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40572 · Cited by 132
de Groot, R. P., Auwerx, J. H., Bourouis, M., & Sassone‐Corsi, P. (1993) · PubMed · Cited by 128
Wnt Signaling in Mammalian Development: Lessons from Mouse GeneticsPreprint
Wang, J., Sinha, T., & Wynshaw-Boris, A. J. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007963 · Cited by 128
Liu, J., Ding, X., Tang, J., Cao, Y., Hu, P., Zhou, F., Shan, X., Cai, X.-F., Chen, Q., Ling, N., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027496 · Cited by 127
Georgievska, B., Sandin, J., Doherty, J., Mörtberg, A., Neelissen, J. A. M., Andersson, A., Gruber, S. H. M., Nilsson, Y., Schött, P. A., Arvidsson, P. I., et al. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12203 · Cited by 125
GSK-3-Mediated Phosphorylation Enhances Maf-Transforming Activity
Rocques, N., Zeid, N. A., Sii-Felice, K., Lecoin, L., Felder‐Schmittbuhl, M., Eychène, A., & Pouponnot, C. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.009 · Cited by 125
Brady, M., Bourbonais, F., & Saltiel, A. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14063 · Cited by 124
Hsu, W., Shakya, R., & Costantini, F. D. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200107066 · Cited by 123
Martelli, A. M., Chiarini, F., Evangelisti, C., Cappellini, A., Buontempo, F., Bressanin, D., Fini, M., & McCubrey, J. A. (2012) · Oncotarget · doi:10.18632/oncotarget.477 · Cited by 122
Self-citationPotential Therapeutic Effect of Glycogen Synthase Kinase 3β Inhibition against Human Glioblastoma
Miyashita, K., Kawakami, K., Nakada, M., Mai, W., Shakoori, A., Fujisawa, H., Hayashi, Y., Hamada, J., & Minamoto, T. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0760 · Cited by 122
Bakre, M. M., Hoi, A., Mong, J. C. Y., Koh, Y. Y., Wong, K., & Stanton, L. W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704287200 · Cited by 120
Liu, B., Fan, Z., Edgerton, S. M., Yang, X., Lind, S. E., & Thor, A. D. (2011) · Cell Cycle · doi:10.4161/cc.10.17.16359 · Cited by 120
Liu, L., Dai, Y., Chen, J., Zeng, T., Li, Y., Chen, L., Zhu, Y.-H., Li, J., Ma, S., Xie, D., et al. (2013) · Hepatology · doi:10.1002/hep.26677 · Cited by 120
The Role of Glycogen Synthase Kinase 3β in the Transformation of Epidermal Cells
Ma, C., Wang, J., Gao, Y., Gao, T., Chen, G., Bower, K. A., Odetallah, M., Ding, M., Ke, Z., & Luo, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4665 · Cited by 119
Glycogen synthase kinase 3β is tyrosine phosphorylated by PYK2
Hartigan, J. A., Xiong, W.-C., & Johnson, G. V. W. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4986 · Cited by 117
MiRNA-34 intrinsically links p53 tumor suppressor and Wnt signaling
Cha, Y. H., Kim, N. H., Park, C., Lee, I., Kim, H. S., & Yook, J. I. (2012) · Cell Cycle · doi:10.4161/cc.19618 · Cited by 115
GSK-3 Is Activated by the Tyrosine Kinase Pyk2 during LPA1-mediated Neurite Retraction
Sayas, C. L., Ariaens, A., Ponsioen, B., & Moolenaar, W. H. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-07-0688 · Cited by 115
Weber, G. L., Parat, M., Binder, Z. A., Gallia, G. L., & Riggins, G. J. (2011) · Oncotarget · doi:10.18632/oncotarget.346 · Cited by 114
Sharma, A. K. (2011) · Cited by 113
Protein kinase CK2: signaling and tumorigenesis in the mammary gland.
Landesman‐Bollag, E., Song, D. H., Romieu, R., Sussman, D. J., Cardiff, R. D., Sonenshein, G. E., & Seldin, D. C. (2001) · PubMed · Cited by 111
Characterisation of the phosphorylation of β-catenin at the GSK-3 priming site Ser45
Hagen, T., & Vidal‐Puig, A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00485-0 · Cited by 110
Wen, W., Ding, J., Sun, W. C., Fu, J., Chen, Y., Wu, K., Ning, B., Han, T., Huang, L., Chen, C. Y., et al. (2012) · Hepatology · doi:10.1002/hep.25596 · Cited by 109
Oliveras‐Ferraros, C., Cufí, S., Vázquez‐Martín, A., Torres-Garcia, V. Z., Barco, S. D., Martı́n-Castillo, B., & Menéndez, J. A. (2011) · Cell Cycle · doi:10.4161/cc.10.7.15210 · Cited by 109
Mai, W., Kawakami, K., Shakoori, A., Kyo, S., Miyashita, K., Yokoi, K., Jin, M., Shimasaki, T., Motoo, Y., & Minamoto, T. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0973 · Cited by 109
Haraguchi, M., Okubo, T., Miyashita, Y., Miyamoto, Y., Hayashi, M., Crotti, T. N., McHugh, K. P., & Ozawa, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801125200 · Cited by 107
The Development of New Therapeutics for Alzheimer's Disease
Carter, M. D., Simms, G. A., & Weaver, D. F. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.165 · Cited by 107
INPP4B: the New Kid on the PI3K Block
Agoulnik, I. U., Hodgson, M. C., Bowden, W. A., & Ittmann, M. (2011) · Oncotarget · doi:10.18632/oncotarget.260 · Cited by 106
Banerji, V., Frumm, S. M., Ross, K. N., Li, L. S., Schinzel, A. C., Hahn, C. K., Kakoza, R. M., Chow, K. T., Ross, L., Alexe, G., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci46465 · Cited by 105
Role of Glycogen Synthase Kinase 3β in Rapamycin-Mediated Cell Cycle Regulation and Chemosensitivity
Dong, J., Peng, J., Zhang, H., Mondesire, W. H., Jian, W., Mills, G. B., Hung, M., & Meric‐Bernstam, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2501 · Cited by 104
Grimaldi, C., Chiarini, F., Tabellini, G., Ricci, F., Tazzari, P. L., Battistelli, M., Falcieri, E., Bortul, R., Melchionda, F., Iacobucci, I., et al. (2011) · Leukemia · doi:10.1038/leu.2011.269 · Cited by 104
Self-citationYuan, H., Mao, J., Li, L., & Wu, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30419 · Cited by 104
Wang, H., Brown, J. R., Gu, Z., Garcia, C. A., Liang, R., Alard, P., Beurel, E., Jope, R. S., Greenway, T., & Martin, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002513 · Cited by 104
β‐catenin as a potential key target for tumor suppression
Fu, Y., Zheng, S., An, N., Athanasopoulos, T., Popplewell, L. J., Liang, A., Li, K., Hu, C., & Zhu, Y. (2011) · International Journal of Cancer · doi:10.1002/ijc.26102 · Cited by 102
Sufu recruits GSK3β for efficient processing of Gli3
Kise, Y., Morinaka, A., Teglund, S., & Miki, H. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.087 · Cited by 101
Bianchi, M., Lucchini, S. D., Marin, O., Turner, D. L., Hanks, S. K., & Villa-Moruzzi, E. (2005) · Biochemical Journal · doi:10.1042/bj20050282 · Cited by 100
Valvezan, A. J., Zhang, F., Diehl, J. A., & Klein, P. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.323337 · Cited by 100
mTORC1 signaling governs hematopoietic stem cell quiescence
Gan, B., & DePinho, R. A. (2009) · Cell Cycle · doi:10.4161/cc.8.7.8045 · Cited by 99
Jagged1 Expression Regulated by Notch3 and Wnt/β-catenin Signaling Pathways in Ovarian Cancer
Xu, C., Stoeck, A., Lee, S. J., Shih, I., Wang, M. M., & Wang, T. (2010) · Oncotarget · doi:10.18632/oncotarget.127 · Cited by 97
Jho, E., Lomvardas, S., & Costantini, F. D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1760 · Cited by 97
Glycogen Synthase Kinase-3 and Cancer: Good Cop, Bad Cop?
Patel, S., & Woodgett, J. R. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.013 · Cited by 97
Acquired Radioresistance of Cancer and the AKT/GSK3β/cyclin D1 Overexpression Cycle
Shimura, T. (2011) · Journal of Radiation Research · doi:10.1269/jrr.11098 · Cited by 97
Protein kinase CK2: Signaling and tumorigenesis in the mammary gland
Landesman‐Bollag, E., Song, D. H., Romieu, R., Sussman, D. J., Cardiff, R. D., Sonenshein, G. E., & Seldin, D. C. (2001) · Molecular and Cellular Biochemistry · doi:10.1023/a:1013108822847 · Cited by 93
Steelman, L. S., Navolanic, P. M., Chappell, W. H., Abrams, S. L., Wong, E. W. T., Martelli, A. M., Cocco, L., Stivala, F., Libra, M., Nicoletti, F., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.17.17119 · Cited by 89
Self-citationHagen, T., Daniel, E. D., Culbert, A. A., & Reith, A. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201364200 · Cited by 89
The Regulation of Glycogen Synthase Kinase-3 Nuclear Export by Frat/GBP
Franca‐Koh, J., Yeo, M., Fraser, E., Young, N., & Dale, T. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207265200 · Cited by 88
Cai, X., Li, M., Vrana, J. A., & Schaller, M. D. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2857-2868.2006 · Cited by 87
Zheng, H., Li, W., Wang, Y., Liu, Z., Cai, Y., Xie, T., Shi, M. Q., Wang, Z., & Jiang, B. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.03.014 · Cited by 86
Arciuch, V. G. A., Russo, M. A., Dima, M., Kang, K. S., Dasrath, F., Liao, X.-H., Refetoff, S., Montagna, C., & Cristofano, A. D. (2011) · Oncotarget · doi:10.18632/oncotarget.380 · Cited by 85
Mcl-1 Ubiquitination and Destruction
Inuzuka, H., Fukushima, H., Shaik, S., Liu, P., Lau, A. W., & Wei, W. (2011) · Oncotarget · doi:10.18632/oncotarget.242 · Cited by 85
Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings
Trepiccione, F., & Christensen, B. M. (2010) · Journal of Nephrology · doi:10.1093/joneph/23.s16.s43 · Cited by 85
Involvement of Akt-1 and mTOR in Sensitivity of Breast Cancer to Targeted Therapy
Sokolosky, M. L., Stadelman, K. M., Chappell, W. H., Abrams, S. L., Martelli, A. M., Stivala, F., Libra, M., Nicoletti, F., Дробот, Л. Б., Franklin, R. A., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.302 · Cited by 84
Self-citationRegulation of Notch1/NICD and Hes1 Expressions by GSK-3α/β
Jin, Y. H., Kim, H., Oh, M., Ki, H., & Kim, K. (2009) · Molecules and Cells · doi:10.1007/s10059-009-0001-7 · Cited by 84
PI3K/mTORC1 activation in hamartoma syndromes: Therapeutic prospects
Krymskaya, V. P., & Goncharova, E. A. (2009) · Cell Cycle · doi:10.4161/cc.8.3.7555 · Cited by 84
Polarity proteins PAR6 and aPKC regulate cell death through GSK-3β in 3D epithelial morphogenesis
Kim, M., Datta, A., Brakeman, P., Yu, W., & Mostov, K. E. (2007) · Journal of Cell Science · doi:10.1242/jcs.007443 · Cited by 83
Cited by
Targeting PI3K/Akt signal transduction for cancer therapy
He, Y., Sun, M. M., Zhang, G. G., Yang, J., Chen, K. S., Xu, W. W., & Li, B. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00828-5 · Cited by 1,892
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Cuadrado, A., Manda, G., Hassan, A., Alcaraz, M. J., Barbas, C., Daiber, A., Ghezzi, P., León, R., López, M. G., Oliva, B., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014753 · Cited by 632
Genetics, diagnosis and management of colorectal cancer (Review)
DE ROSA, M., PACE, U., REGA, D., COSTABILE, V., DURATURO, F., IZZO, P., & DELRIO, P. (2015) · Oncology Reports · doi:10.3892/or.2015.4108 · Cited by 317
Acetyl-CoA metabolism in cancer
Guertin, D. A., & Wellen, K. E. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00543-5 · Cited by 303
Targeting GSK3 and Associated Signaling Pathways Involved in Cancer
Duda, P., Akula, S. M., Abrams, S. L., Steelman, L. S., Martelli, A. M., Cocco, L., Ratti, S., Candido, S., Libra, M., Montalto, G., et al. (2020) · Cells · doi:10.3390/cells9051110 · Cited by 284
Self-citation
Metadata
- Authors
- McCubrey, J. A., Steelman, L. S., Bertrand, F. E., Davis, N. M., Sokolosky, M., Abrams, S. L., Montalto, G., D’Assoro, A. B., Libra, M., Nicoletti, F., Maestro, R., Basecke, J., Rakus, D., Gizak, A., Demidenko, Z., Cocco, L., Martelli, A. M., & Cervello, M.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2014-05-28
- Volume
- 5
- Issue
- 10
- Pages
- 2881-2911
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1716978847
- Cited by
- 508
- References
- 296
- FWCI
- 19.35
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.